Nicole Lee Jacklitsch Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Jackie Ct, Chester, NY 10918 Phone: 845-544-3392 |
Thomas Derian Ogrodnik, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 |
Ms. Mae Resa Card, P.T., D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Overlook Trail, Chester, NY 10918 Phone: 315-512-1773 Fax: 315-512-1774 |
Dr. Samuel D O'keefe, PT DPT CSCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 |
Isabel Blanco, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Gibson Hill Rd, Chester, NY 10918 Phone: 845-469-5092 |
Ms. Isabel A. Blanco, PT, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Gibson Hill Road, Chester, NY 10918 Phone: 845-469-5092 |
Austin Frost Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 |
Kurt Henry Fluhler, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 |
Melissa A Coombs, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 Fax: 845-469-2269 |
Tebble Cassel, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 Fax: 845-469-2269 |
News Archive
Voters had more confidence in how GOP challenger Mitt Romney would handle the economy. Meanwhile, Rick Santorum, who previously had been a candidate in the Republican presidential primary, offered a late-night e-mail endorsement to Romney.
The U.S. Air Force Suicide Prevention Program (AFSPP) has reduced suicide rates significantly since it was launched in 1996, according to a new study that examined almost three decades of data.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Cancer presents an ongoing challenge for physicians, particularly in the diagnosis and treatment of the disease. This is, amongst other things, due to tumor heterogeneity.
› Verified 5 days ago